Assuming 30 trading days horizon, Integrated Biopharma Inc. is expected to generate 53.05 times more return on investment than Auxilium. However, Integrated is 53.05 times more volatile than Auxilium Pharmaceuticals Inc.. It trades about 0.2 of its potential returns per unit of risk. Auxilium Pharmaceuticals Inc. is currently generating about 0.14 per unit of risk. If you would invest 3.00 in Integrated Biopharma Inc. on April 26, 2012 and sell it today you would earn a total of 4.00 from holding Integrated Biopharma Inc. or generate 133.33% return on investment over 30 days.
Diversification
Significant diversification
Overlapping area represents amount of risk that can be diversified away by holding Integrated Biopharma Inc. and Auxilium Pharmaceuticals Inc. in the same portfolio (assuming nothing else is changed)
92% of all equities and portfolios perform better than Integrated Biopharma Inc.. Compared with the overall equity markets, risk-adjusted returns on investments in Integrated Biopharma Inc. are ranked lower than 8 (%) of all global equities and portfolios over the last 30 days.
94% of all equities and portfolios perform better than Auxilium Pharmaceuticals Inc.. Compared with the overall equity markets, risk-adjusted returns on investments in Auxilium Pharmaceuticals Inc. are ranked lower than 6 (%) of all global equities and portfolios over the last 30 days.
USA 
Select Assests
Optimize Portfolio
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatilities
Import Equities
Search Equities
